Maintenance Therapy with Intravesical Bacillus Calmette-Guérin in Patients with Intermediate- or High-risk Non-muscle-invasive Bladder Cancer

By Muto Satoru   Nakajima Akiko   Horiuchi Akira   Inoue Masayuki   China Toshiyuki   Saito Keisuke   Isotani Shuji   Hisasue Shin-ichi   Yamaguchi Raizo   Ide Hisamitsu   Horie Shigeo  

Japanese Journal of Clinical Oncology, Vol. 43, Iss. 3, 2013-03 ,pp. : 305-313

Oxford University Press

Access to resources Recommend Favorite

Pyuria predicts poor prognosis in patients with non-muscle-invasive bladder cancer treated with bacillus Calmette-Guérin

By      

Molecular and Clinical Oncology, Vol. 3, Iss. 5, 2015-01 ,pp. : 1113-1116

Science Publishers

Access to resources Recommend Favorite

Monthly intravesical bacillus Calmette-Guérin maintenance therapy for non-muscle-invasive bladder cancer: 10-year experience in a single institute

By      

Experimental and Therapeutic Medicine, Vol. 3, Iss. 2, 2012-01 ,pp. : 221-225

Spandidos Publications

Access to resources Recommend Favorite

The Efficacy of Intravesical Bacillus Calmette-Guerin in the Treatment of Patients with pT1 Stage Non-muscle-invasive Bladder Cancer

By Ajili Faouzia  

Ultrastructural Pathology, Vol. 37, Iss. 4, 2013-08 ,pp. : 278-283

Informa Healthcare

Access to resources Recommend Favorite

The Efficiency of the EORTC Scoring System for the Prediction of Recurrence and Progression of Non-muscle-invasive Bladder Cancer Treated by Bacillus Calmette-Guerin Immunotherapy

By Ajili Faouzia  

Ultrastructural Pathology, Vol. 37, Iss. 4, 2013-08 ,pp. : 249-253

Informa Healthcare

Access to resources Recommend Favorite